BRVE
Braveheart Bio, Inc.
Set alert
21.51 USD +0.32 +1.51%
20.75 Day range 21.77
18.58 52-week range 30.00
- YTD
- -27.82%
- 1 year
- -27.82%
- Open
- 21.29
- Prev close
- 21.19
- Mkt cap
- 1.94B
- Vol
- 533.67K
- Avg vol
- 479.98K
- EPS
- -6.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.75
- High
- 21.77
- Forward P/E
- -10.74
- Beta
- 0.00
- Short ratio
- 8.11
- Inst. own
- 28.16%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 8, 2026
- 50-d avg
- 23.64
- 200-d avg
- 24.28
- 1y target
- 45.25
Ownership
Held by insiders 58.16%
Held by institutions 28.16%
Float held by institutions 67.30%
Institutions 17
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Leonard Rickey Investment Advisors P.L.L.C. | 0.04% | 36,109 | 771.83K | Sep 29, 2026 |
| SBI Securities Co., Ltd. | 0.00% | 10 | 213 | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 2.52% | 2,273,151 | 48.59M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 0.87% | 779,600 | 16.66M | Aug 30, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 0.67% | 600,000 | 12.82M | Aug 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.60% | 537,444 | 11.49M | Aug 30, 2026 |
| MFS SERIES TRUST I-MFS New Discovery Fund | 0.38% | 345,984 | 7.40M | Aug 30, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 0.30% | 265,638 | 5.68M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHIMOVITS EREZ | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 6, 2026 | 0 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 6, 2026 | 7,420,090 |
| LUBNER DAVID CHARLES | Director | Purchase | Aug 6, 2026 | 55,555 |
| MURDOCH TRAVIS | Chief Executive Officer | Purchase | Aug 6, 2026 | 8,333,640 |
| RICKEY JAMES PAUL | Chief Financial Officer | Purchase | Aug 6, 2026 | 703,575 |
| VIEHBACHER CHRISTOPHER | Director | Purchase | Aug 6, 2026 | 759,857 |
Held by funds
38 US ETFs and mutual funds hold BRVE · largest positions